Connection

Xiaoyang Zhou to Allografts

Back to Details
This is a "connection" page, showing publications Xiaoyang Zhou has written about Allografts.
Xiaoyang Zhou
Connection Strength
0.042
Allografts
  1. Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trial. Clin Transl Med. 2021 02; 11(2):e297.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.